Page last updated: 2024-11-04

benzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzoic Acid: A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

benzoic acid : A compound comprising a benzene ring core carrying a carboxylic acid substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

aromatic carboxylic acid : Any carboxylic acid in which the carboxy group is directly bonded to an aromatic ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
GlycinegenusA non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID243
CHEMBL ID541
CHEBI ID30746
SCHEMBL ID1378
MeSH IDM0029415

Synonyms (231)

Synonym
BIDD:ER0597
CHEBI:30746 ,
benzoesaeure
e210
benzoic acid (jp17/usp)
D00038
benzoic acid (tn)
acide benzoique [french]
acido benzoico [italian]
benzoesaeure [german]
benzoate (van)
einecs 200-618-2
benzoic acid [usan:jan]
diacylic acid
benzenemethonic acid
kyselina benzoova [czech]
nsc 149
oracylic acid
inchi=1/c7h6o2/c8-7(9)6-4-2-1-3-5-6/h1-5h,(h,8,9
salvo liquid
caswell no. 081
ccris 1893
hsdb 704
ai3-03710
ai3-0310
solvo powder
e 210
ha 1 (acid)
epa pesticide chemical code 009101
fema no. 2131
benzoic acid (natural)
unisept bza
benzoic acid (7ci,8ci,9ci)
ha 1
NCGC00091886-01
STK301730
salvo, liquid
phenylcarboxylic acid
C00539
C00180
benzoesaeure gv
dracylic acid
nsc149
carboxybenzene
benzenecarboxylic acid
wln: qvr
benzeneformic acid
solvo, powder
retardex
retarder ba
acide benzoique
nsc-149
benzoesaeure gk
phenylformic acid
benzoic acid
65-85-0
aromatic acid
kyselina benzoova
benzenemethanoic acid
tenn-plas
aromatic carboxylic acid
benzoic acid, tech.
benzoic acid, >=99.5%, fcc, fg
benzoic acid, analytical standard
benzoic acid, natural, >=99.5%, fcc, fg
scavengepore(tm) benzoic acid, macroporous, 40-70 mesh, extent of labeling: 0.5-1.5 mmol per g loading
1KQB
1GYX
DB03793
benzoic acid, acs reagent, >=99.5%
benzoic acid, reagentplus(r), 99%
acid, benzoic
benzoic acid, purified by sublimation, >=99%
benzoic acid, meets analytical specification of ph. eur., bp, usp, fcc, e210, 99.5-100.5% (alkalimetric)
benzoic acid, puriss. p.a., acs reagent, reag. ph. eur., >=99.9% (alkalimetric)
smr001252220
MLS002415717
0BE368DC-6DE6-4927-AECF-E4BB2968A4A0
HMS2092F18
B0062
B2635
BMSE000300
CHEMBL541
ins no.210
menno-florades
benzoicum acidum
benzoic acid (e 210)
acidum benzoicum
vevovitall
e-210
ins-210
FT-0662569
FT-0662570
AKOS000119619
A835250
NCGC00091886-03
NCGC00091886-02
8skn0b0mim ,
unii-8skn0b0mim
benzoic acid [usp:jan]
ec 200-618-2
acido benzoico
NCGC00254112-01
tox21_202403
dtxsid6020143 ,
tox21_300180
NCGC00259952-01
cas-65-85-0
dtxcid80143
nsc-758203
nsc758203
pharmakon1600-01503001
HMS2267D03
S4161
FT-0622705
EPITOPE ID:139965
BP-30148
b a
methylaminolevulinate hydrochloride impurity i [ep]
benzoic acid [ii]
benzoic acid [fhfi]
benzoic acid [hsdb]
benzoic acid [mart.]
glycopyrronium bromide impurity d [ep impurity]
benzoic acid [green book]
benzoic acid [who-ip]
tiaprofenic acid impurity d [ep]
benzoic acid [who-dd]
benzoic acid [inci]
acidum benzoicum [who-ip latin]
benzoic acid [jan]
benzoic acid [ep monograph]
benzoic acid [mi]
benzoic acid [vandf]
benzoicum acidum [hpus]
mefenamic acid impurity d [ep impurity]
benzoic acid [usp-rs]
metronidazole benzoate impurity c [ep impurity]
hydrous benzoyl peroxide impurity b [ep impurity]
benzoic acid [fcc]
benzoic acid [usp monograph]
CCG-213088
SCHEMBL1378
Z57127480
benzene-2-carboxylic acid
benzoic aicd
diacylate
benzoic- acid
bezoic acid
phenylcarboxy
retarder bax
salvo powder
BS-3752
ss benzoic acid, 2000 mug/ml in dichloromethane, analytical standard
AB00949635_05
AB00949635_06
sampl4, o1
37960-84-2
mfcd00002400
mfcd00002398
benzoic-2,3,4,5,6-d5 acid
F2191-0092
melting point standard 121-123c, analytical standard
benzoic acid, meets usp testing specifications
mettler-toledo calibration substance me 18555, benzoic acid, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (lgc)
fema 2131
SR-05000001919-1
sr-05000001919
benzoic acid, for calorimetrical determination (approx. 26460 j/g)
benzoic acid, certified reference material for titrimetry, certified by bam according to iso 17025, >=99.5%
benzoic acid, tested according to ph.eur.
benzoic acid, saj first grade, >=99.5%
benzoic acid, saj special grade, >=99.5%
benzoic acid, united states pharmacopeia (usp) reference standard
benzoic acid, standard for quantitative nmr, tracecert(r)
HMS3652B03
sodium benzoic acid
dracylate
D85168
bdbm197302
benzoic acid, usp, 99.5-100.5%
benzoic acid, p.a., 99.5%
benzoic acid, puriss. p.a., acs reagent, 99.9%
benzoic acid, ar, >=99%
benzoic acid, nist(r) srm(r) 39j, calorimetric standard
benzoic acid, pharmaceutical secondary standard; certified reference material
benzoic acid, european pharmacopoeia (ep) reference standard
benzoic acid, vetec(tm) reagent grade, 98%
benzoic acid, lr, >=99%
benzoic acid 100 microg/ml in acetone
SBI-0206720.P001
SW219833-1
benzoic acid, acs reagent
CS-0008257
FT-0770591
mettler-toledo calibration substance me 18555, benzoic acid
HY-N0216
benzoic-3,5-d2 acid
benzoic acid,(s)
benzoic acid zone refined (number of passes:20)
benzoic-4-d1 acid
Q191700
benzoic-acid
benzenecarboxylic
benzoicacid-d5
benzoic acid-2,3,4,5,6-d5
SY009192
A934445
benzoic acid 2000 microg/ml in dichloromethane
SY236257
EN300-18007
14322-82-8
benzoic acid (ep monograph)
benzene carboxylic acid
benzoic acid (mart.)
dracyclic acid
benzoic acid (usp monograph)
benzoic acid (usp-rs)
diacyclic acid
usepa/opp pesticide code: 009101
benzoic acid (usp:jan)
rheumatism diarrhea
carboxylbenzene
benzoicum ac
provitacombat
benzoic acid (ii)
provita equiband
eyelids wipes
760 - preservatives
31 - preservatives in mascara
27 - preservatives in cream

Research Excerpts

Overview

Benzoic acid (BA) is an important platform aromatic compound in chemical industry. It is widely used as food preservatives in its salt forms. It can be found in root exudates and rhizosphere soil of crops and inhibits crop growth.

ExcerptReferenceRelevance
"Benzoic acid is a representative allelochemical found in root exudates and rhizosphere soil of crops and inhibits crop growth."( Complete Genome Sequence and Biodegradation Characteristics of Benzoic Acid-Degrading Bacterium
Huang, R; Li, L; Tang, H; Wei, X; Xiang, W, 2020
)
1.52
"Benzoic acid (BA) is an important platform aromatic compound in chemical industry and is widely used as food preservatives in its salt forms. "( Metabolic engineering of Escherichia coli for the production of benzoic acid from glucose.
Lee, SY; Luo, ZW, 2020
)
2.24
"Benzoic acid is a building block of a multitude of well-known plant natural products, such as paclitaxel and cocaine. "( Cytosolic aromatic aldehyde dehydrogenase provides benzoic acid for xanthone biosynthesis in Hypericum.
Awadalah, M; Beerhues, L; Gaid, M; Hänsch, R; Kaufholdt, D; Singh, P, 2021
)
2.32
"Benzoic acid functions as an efficient catalyst in this three-component reaction of cyclic secondary amines, aldehydes and phosphine oxides to provide rapid access to α-amino phosphine oxides not easily accessible by classic Kabachnik-Fields reactions."( Redox-neutral α-C-H bond functionalization of secondary amines with concurrent C-P bond formation/N-alkylation.
Das, D; Seidel, D, 2013
)
1.11
"Benzoic acid is a typical substrate for monocarboxylic acid transporters (MCTs), and easily taken up from the apical membranes of Caco-2 cells by MCTs. "( Steric hindrance of 2,6-disubstituted benzoic acid derivatives on the uptake via monocarboxylic acid transporters from the apical membranes of Caco-2 cells.
Endo, T; Kimura, O; Tsukagoshi, K, 2014
)
2.12
"Benzoic acid is an aromatic carboxylic acid naturally present in plant and animal tissues, which can also be produced by microorganisms. "( Benzoic acid and its derivatives as naturally occurring compounds in foods and as additives: Uses, exposure, and controversy.
Calzada, J; Del Olmo, A; Nuñez, M, 2017
)
3.34
"Benzoic acid is a model compound for drug substances in pharmaceutical research. "( Benzoic Acid and Chlorobenzoic Acids: Thermodynamic Study of the Pure Compounds and Binary Mixtures With Water.
Held, C; Reschke, T; Verevkin, SP; Zherikova, KV, 2016
)
3.32
"The benzoic acid acts as a scavenger of OH radical due to which the decarboxylation of benzoic acid cured."( Remediation of Cu metal-induced accelerated Fenton reaction by potato peels bio-sorbent.
Azmat, R; Moin, S; Saleem, A, 2016
)
0.92
"Benzoic acid (BA) is an important building block in a wide spectrum of compounds varying from primary metabolites to secondary products. "( Involvement of snapdragon benzaldehyde dehydrogenase in benzoic acid biosynthesis.
Dudareva, N; Ho, KK; Kaminaga, Y; Kish, CM; Long, MC; Nagegowda, DA; Rhodes, D; Schnepp, J; Sherman, D; Weiner, H, 2009
)
2.04
"Benzoic acid (Bz) is a prickling compound used to preserve foods. "( Differential changes in taste perception induced by benzoic acid prickling.
Otero-Losada, ME, 2003
)
2.01
"Benzoic Acid is an aromatic acid used in a wide variety of cosmetics as a pH adjuster and preservative."( Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate.
Nair, B, 2001
)
1.28
"Benzoic acid is a simple competitive inhibitor of the cresolase reaction of all three isozymes."( Benzoic acid inhibition of the alpha, beta, and gamma isozymes of Agaricus bisporus tyrosinase.
Fleck, RW; Menon, S; Strothkamp, KG; Yong, G, 1990
)
2.44

Effects

Benzoic acid is prohibited to add as a preservative in dairy products. It has apoptotic effects at concentrations higher than 5 mM. We tested concentrations less than 5mM.

ExcerptReferenceRelevance
"Benzoic acid, which has a pivotal role in food additive, is prohibited to add as a preservative in dairy products. "( SERS Detection of Benzoic Acid in Milk by Using Ag-COF SERS Substrate.
Chen, G; Gao, H; Gu, J; Li, L; Ma, C; Shang, Y; Wang, C; Wang, Z; Wu, Y; Yang, Z; Yin, W; Zhang, Y; Zhu, C, 2022
)
2.5
"Benzoic acid, which has a pivotal role in food additive, is prohibited to add as a preservative in dairy products. "( SERS Detection of Benzoic Acid in Milk by Using Ag-COF SERS Substrate.
Chen, G; Gao, H; Gu, J; Li, L; Ma, C; Shang, Y; Wang, C; Wang, Z; Wu, Y; Yang, Z; Yin, W; Zhang, Y; Zhu, C, 2022
)
2.5
"Benzoic acid has apoptotic effects at the concentrations higher than 5 mM, for this reason we tested concentrations less than 5mM (0.05, 0.1, 0.5, 1 and 5 mM)."( Assessment of genotoxic effects of benzyl derivatives by the comet assay.
Demir, E; Kaya, B; Kocaoğlu, S, 2010
)
1.08

Treatment

The treatments suppressed root growth by 30.5%, 58.8% and 81.1% with increasing concentrations. By treating benzoic acid and BTEX compounds with slow-release persulfate and ZVI candles, we observed rapid transformation of all contaminants.

ExcerptReferenceRelevance
"The benzoic acid treatments suppressed root growth by 30.5%, 58.8% and 81.1% with increasing concentrations."( Cellular evidence of allelopathic interference of benzoic acid to mustard (Brassica juncea L.) seedling growth.
Kaur, H; Kaushik, S, 2005
)
1.06
"By treating benzoic acid and BTEX compounds with slow-release persulfate and ZVI candles, we observed rapid transformation of all contaminants."( Developing slow-release persulfate candles to treat BTEX contaminated groundwater.
Chokejaroenrat, C; Comfort, S; Kambhu, A; Sakulthaew, C, 2012
)
0.74

Toxicity

Benzoic acid and Sodium Benzoate generally recognized as safe in foods according to the U.S. Food and Drug Administration.

ExcerptReferenceRelevance
" In whole animals, inhibition of pyruvate carboxylase may contribute to benzoate toxicity and the adverse influence of glyoxylate on benzoate therapy."( Potentiation of benzoate toxicity by glyoxylate. Inhibition of pyruvate carboxylase and the urea cycle.
Cyr, DM; Tremblay, GC, 1989
)
0.28
" Preadministration of thiamin and especially of thiamin diphosphate decreased the toxic effect of cyclophosphamide."( [Metabolism and toxicity of various xenobiotics in vitamin B1 deficiency and after administration of thiamine and thiamine diphosphate].
Lutsiuk, NB; Lychko, AP; Pentiuk, AA,
)
0.13
" Cerebellar granule cells at 12 days in culture when treated with a toxic dose of glutamate (100 microM) showed a rapid and transient increase of polyADP-ribose immunoreactivity."( Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells.
Cosi, C; Facci, L; Kanai, Y; Menegazzi, M; Milani, D; Skaper, SD; Suzuki, H; Vantini, G, 1994
)
0.29
" The differences observed in the cytotoxicity of these compounds, along with other properties, may assist the dental practitioners in the selection of reline materials with improved service life performance and low risk of adverse reactions in patients who wear relined dentures."( Cytotoxicity of monomers, plasticizer and degradation by-products released from dental hard chairside reline resins.
Carlos, IZ; Chaves, CA; Giampaolo, ET; Machado, AL; Pavarina, AC; Vergani, CE, 2010
)
0.36
" The toxicity of the residual PCBs after nano-bio treatment was evaluated in terms of toxic equivalent values which decreased from 33."( Nano/bio treatment of polychlorinated biphenyls with evaluation of comparative toxicity.
Chang, YS; Francis, AJ; Jeon, JR; Le, TT; Nguyen, KH, 2015
)
0.42
" These observations confirm that the drug metabolites generated after CocH gene transfer therapy are safe even after a dose of cocaine that would ordinarily be lethal."( Reward and Toxicity of Cocaine Metabolites Generated by Cocaine Hydrolase.
Brimijoin, S; Gao, Y; Geng, L; Miller, JD; Murthy, V; Reyes, S; Zhang, B, 2015
)
0.42
" After reviewing newly available data, it was concluded that benzyl alcohol, benzoic acid and its salts, and benzyl benzoate are safe in the present practices of use and concentration described in this safety assessment."( Safety Assessment of Benzyl Alcohol, Benzoic Acid and its Salts, and Benzyl Benzoate.
Andersen, FA; Belsito, DV; Bergfeld, WF; Hill, RA; Johnson, W; Klaassen, CD; Liebler, DC; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW,
)
0.63

Pharmacokinetics

The aim of this study was to determine the pharmacokinetic profiles of BOH and its metabolites benzoic acid and hippuric acid simultaneously in serum to estimate the BOH release out of the depot.

ExcerptReferenceRelevance
" In the 7 control subjects, the mean level (+/- SEM) of Cmax for serum benzoate was 104."( Clinical significance of benzoate-metabolizing capacity in patients with chronic liver disease: pharmacokinetic analysis.
Amisaki, T; Fujii, T; Hasegawa, M; Hoshino, U; Kobayashi, J; Suou, T; Tabuchi, F; Takayama, M; Yamada, S; Yamamoto, T, 1992
)
0.28
" A three-compartment pharmacokinetic model used to stimulate mass transfer from the surface (C1), diffusion through epidermis and dermis (C2), and transfer into the capillary perfusate (C3), was developed based on flux through the IPPSF from 0 to 8 hr."( The isolated perfused porcine skin flap. III. Percutaneous absorption pharmacokinetics of organophosphates, steroids, benzoic acid, and caffeine.
Carver, MP; Riviere, JE; Williams, PL, 1989
)
0.49
"This paper demonstrates that the stable isotope tracer technique using NMR spectroscopy and the selective 13C labeling of protonated carbons can provide a relatively sensitive method to investigate pharmacokinetic problems in man."( Use of nuclear magnetic resonance spectroscopy and selective C-labeling for pharmacokinetic research in man: detection of benzoic acid conversion to hippuric acid.
Akira, K; Baba, S; Imachi, M; Suzuki, H, 1995
)
0.5
"1 T, 92 MHz 2H frequency) in a simple pharmacokinetic problem has now been investigated using selectively deuterated benzoic acid (BA) as a model."( High-field deuterium nuclear magnetic resonance spectroscopic monitoring of the pharmacokinetics of selectively deuterated benzoic acid in man.
Akira, K; Caddick, ST; Farrant, RD; Lindon, JC; Nicholls, AW; Nicholson, JK, 1994
)
0.7
" In general, this tracer technique has the potential for wide application to pharmacokinetic research since xenobiotic and endogenous metabolism can be followed by very simple and convenient procedures."( Application of 13C-labeling and nuclear magnetic resonance spectroscopy to pharmacokinetic research: measurement of metabolic rate of benzoic acid to hippuric acid in the rat.
Akira, K; Baba, S; Shindo, H; Takagi, N; Takeo, S, 1993
)
0.49
" Although the C-terminally PEGylated 4 showed some improvements over the un-PEGylated (18)F-FBA-A20FMDV2 (1), it was the bi-terminally PEGylated 5 that displayed the more favorable combination of high αvβ6 affinity, selectivity, and pharmacokinetic profile."( The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Bauer, N; Hausner, SH; Hu, LY; Knight, LM; Sutcliffe, JL, 2015
)
0.42
"The bi-PEGylated radiotracer 5 showed a greatly improved pharmacokinetic profile, beyond what was predicted from individual N- or C-terminal PEGylation."( The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Bauer, N; Hausner, SH; Hu, LY; Knight, LM; Sutcliffe, JL, 2015
)
0.42
" In the pyridine series, compound 7a was found to be a highly potent and selective EP4 antagonist, with suitable rat and dog pharmacokinetic profiles."( Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.
Blanco, MJ; Chambers, M; Chandrasekhar, S; Fisher, MJ; Harvey, A; Lin, C; Mudra, D; Oskins, J; Vetman, T; Wang, XS; Warshawsky, AM; Yu, XP, 2016
)
0.66
" The aim of this study was to determine the pharmacokinetic profiles of BOH and its metabolites benzoic acid and hippuric acid simultaneously in serum to estimate the BOH release out of the depot."( Pharmacokinetics in Elderly Women of Benzyl Alcohol From an Oil Depot.
El Amrani, M; Kalicharan, R; Schot, P; Vromans, H, 2016
)
0.65
" Based on pharmacokinetic data in rodents and humans, we derived a chemical-specific adjustment factor (CSAF) of 2 for the pharmacokinetic component of the interspecies UF."( Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts.
Goodman, JE; Lewandowski, TA; Pizzurro, DM; Zu, K, 2017
)
0.69

Compound-Compound Interactions

ExcerptReferenceRelevance
" The resulting conjugate was used in combination with a prodrug of a benzoic acid mustard alkylating agent to treat human colon tumor xenografts in a two-step targeting strategy, antibody-directed enzyme prodrug therapy (ADEPT)."( Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug.
Bagshawe, KD; Blakey, DC; Boyle, FT; Burke, PJ; East, S; Melton, RG; Springer, CJ; Valcaccia, BE; Wright, AF,
)
0.59
" To achieve this goal, SPE with an enzyme activity (EA) switch combined with mass spectrometry analysis was first proposed."( Rapid screening of neuraminidase inhibitors with the benzoic acid skeleton from Paeonia suffruticosa Andrews by solid-phase extraction with an enzyme activity switch combined with mass spectrometry analysis.
Chen, M; Rong, R; Wang, L; Xing, S; Yang, Y, 2022
)
0.97
" However, the traditional drug combination approaches are restricted with high-cost apparatus, complex and numerous unit operations."( Enabling the drug combination of celecoxib through a spherical co-agglomeration strategy with controllable and stable drug content and good powder properties.
Chen, M; Feng, S; Gao, Y; Gong, J; Guo, S; Han, D; Li, K; Li, T; Tong, L; Wei, J; Yu, C; Zhao, P, 2022
)
0.72

Bioavailability

Rutin, benzoic acid (BA) and triazolofluoroqunolone (TFQ) derivatives were reported. Chemosensitizing effects of rutin or its polymeric micelles (of improved solubility and bioavailability via direct dissolution using Pluronic P123) were verified.

ExcerptReferenceRelevance
"8 hr and bioavailability was 95%."( Bioavailability, metabolism, and renal excretion of benzoic acid in the channel catfish (Ictalurus punctatus).
James, MO; Plakas, SM,
)
0.38
" Furthermore, the luminal stirring increased the absorption rate constant for salicylic acid."( Studies on drug absorption from oral cavity. II. Influence of the unstirred water layer on absorption from hamster cheek pouch in vitro and in vivo.
Hamada, C; Hisaichi, S; Kimura, T; Kurosaki, Y; Nakayama, T, 1987
)
0.27
"In an effort to improve the oral bioavailability of naltrexone [17-(cyclopropylmethyl)-4,5 alpha-epoxy-3,14-dihydroxymorphinan-6-one;1], a number of prodrug esters on the 3-hydroxyl group were prepared: the anthranilate (2), acetylsalicylate (3), benzoate (4), and pivalate (5)."( Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach.
Hussain, MA; Koval, CA; Myers, MJ; Shami, EG; Shefter, E, 1987
)
0.27
" The effect of the volume of the perfusate on the absorption rate constant of phenobarbital, phenol red, tyrosine, and propranolol was studied."( Mechanism of nasal absorption of drugs I: Physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats.
Huang, CH; Hussain, A; Kimura, R; Nassar, RB, 1985
)
0.27
" A reduction of the mucosal unstirred layer thickness by means of the segmented-flow technique considerably increased the absorption rate without essentially changing the shape of the pH-absorption curves."( Drug absorption by the rat jejunum perfused in situ. Dissociation from the pH-partition theory and role of microclimate-pH and unstirred layer.
Högerle, ML; Winne, D, 1983
)
0.27
" Administration of 6-MP with 20% (w/v) sodium benzoate to rat rectum resulted in enhanced absorption and the area under the plasma concentration-time curve was comparable to that obtained by intravenous administration (bioavailability = 100%), while the bioavailability after intrarectal administration of 6-MP with 20% (w/v) sodium hippurate was only 9%."( Improvement of aqueous solubility and rectal absorption of 6-mercaptopurine by addition of sodium benzoate.
Kimura, T; Takeichi, Y, 1994
)
0.29
"Oral bioavailability is a consequence of intestinal absorption, exsorption, and metabolism and is further modulated by the difference in activities among segmental regions."( Absorption of benzoic acid in segmental regions of the vascularly perfused rat small intestine preparation.
Cong, D; Fong, AK; Lee, R; Pang, KS, 2001
)
0.67
" Measurement of the effects of phenolic acids on fluorescein transport across Caco-2 monolayers would be a useful way to evaluate the intestinal absorption or bioavailability of dietary phenolic acids."( Transepithelial transport of fluorescein in Caco-2 cell monolayers and use of such transport in in vitro evaluation of phenolic acid availability.
Hagiwara, K; Konishi, Y; Shimizu, M, 2002
)
0.31
" For caffeine the maximum absorption rate and the total penetration through rat skin were clearly higher than the mean value for human skin."( In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study.
Cage, S; Carmichael, PL; Dick, I; Kenyon, S; Korinth, G; Larese, F; Limasset, JC; Maas, WJ; Montomoli, L; Nielsen, JB; Payan, JP; Robinson, E; Sartorelli, P; Schaller, KH; van Burgsteden, JA; van de Sandt, JJ; Wilkinson, SC; Williams, FM, 2004
)
0.56
" The validated method has been successfully used to analyze human plasma samples for application in pharmacokinetic, bioavailability and bioequivalence studies."( Liquid chromatography/electrospray ionization mass spectrometry method for the quantification of valproic acid in human plasma.
Chidambara, J; Koteshwara, M; Kumar, BR; Manoj, S; Ramakrishna, NV; Santosh, M; Vishwottam, KN, 2005
)
0.33
"A new self-emulsifying drug delivery system (SEDDS) and self-microemulsifying drug delivery system (SMEDDS) have been developed to increase the solubility, dissolution rate, and, ultimately, oral bioavailability of a poorly water soluble drug, carvedilol."( Preparation and evaluation of SEDDS and SMEDDS containing carvedilol.
Nie, S; Pan, W; Sun, P; Wei, L, 2005
)
0.33
" In current risk assessment, oral bioavailability from a specific product is considered to be equal to bioavailability found in toxicity studies in which contaminants are usually ingested via liquids or food matrices."( Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessment.
Brandon, EF; Oomen, AG; Rompelberg, CJ; Sips, AJ; van Engelen, JG; Versantvoort, CH, 2006
)
0.33
" In this way, the oral bioavailability of the antiviral drugs can be improved."( The conformational analysis and proton transfer of neuraminidase inhibitors: a theoretical study.
Fu, Y; Yang, G; Yang, Z; Zhou, L; Zu, Y, 2009
)
0.35
"This study shows the effect of ion pair formation on intestinal absorption and oral bioavailability of amifostine."( Ion-pair strategy for enabling amifostine oral absorption: rat in situ and in vivo experiments.
Bermejo, M; Foroutan, M; González-Álvarez, I; Mangas-Sanjuan, V; Samiei, N; Shafaati, A; Zarghi, A, 2013
)
0.39
" To investigate the feasibility of the co-crystal for improving solubility and a faster dissolution rate in vitro and evaluate the bioavailability and tissue distribution of co-crystal in vivo."( Preparation, characterization, and evaluation of dipfluzine-benzoic acid co-crystals with improved physicochemical properties.
Lin, Y; Wang, J; Yang, C; Yang, H, 2014
)
0.64
" The co-crystal solubility, the rate of drug dissolution and the relative bioavailability were approximately 500 times, five times and double that of dipfluzine, respectively."( Preparation, characterization, and evaluation of dipfluzine-benzoic acid co-crystals with improved physicochemical properties.
Lin, Y; Wang, J; Yang, C; Yang, H, 2014
)
0.64
" Furthermore, the increased relative bioavailability of co-crystal indicated the potential use in further clinical study."( Preparation, characterization, and evaluation of dipfluzine-benzoic acid co-crystals with improved physicochemical properties.
Lin, Y; Wang, J; Yang, C; Yang, H, 2014
)
0.64
" Strategies that may enhance substrate bioavailability such as surfactant production and chemotactic responses toward aromatic compounds were confirmed."( New Findings on Aromatic Compounds' Degradation and Their Metabolic Pathways, the Biosurfactant Production and Motility of the Halophilic Bacterium Halomonas sp. KHS3.
Corti Monzón, G; Herrera Seitz, MK; Murialdo, SE; Nisenbaum, M, 2018
)
0.48
"Co-amorphous drug delivery systems are attracting increasing attention in the pharmaceutical field, due to their promising potential to improve the solubility and bioavailability of poorly water-soluble drugs."( Organic acids as co-formers for co-amorphous systems - Influence of variation in molar ratio on the physicochemical properties of the co-amorphous systems.
Grohganz, H; Löbmann, K; Rades, T; Ueda, H; Wu, W, 2018
)
0.48
" Despite the prominent role of FB in the AP, selective orally bioavailable inhibitors, beyond our own efforts, have not been reported previously."( Discovery of 4-((2
Adams, CM; Anderson, K; April, M; Argikar, UA; Capparelli, M; Crowley, M; Cumin, F; De Erkenez, A; Ding, J; Eder, J; Ehara, T; Erbel, P; Feifel, R; Ferrara, L; Flohr, S; Forster, C; Gerhartz, B; Gradoux, N; Harrison, RA; Jaffee, BD; Jendza, K; Karki, RG; Kawanami, T; Klosowski, DW; Lee, W; Liao, SM; Liu, F; Long, D; Mac Sweeney, A; Maibaum, J; Mainolfi, N; Mogi, M; Ostermeier, D; Powers, J; Prentiss, M; Ramage, P; Ramqaj, R; Schubart, A; Sedrani, R; Sellner, H; Serrano-Wu, M; Sirockin, F; Smith, TM; Solovay, C; Valeur, E; Vogg, B; Wiesmann, C; Yang, L; Zhang, C, 2020
)
0.56
" Among the 12 main components identified, five main compounds were well absorbed with Papp in the order of benzoic acid > chlorogenic acid > astragaloside > hyperoside > rutin."( The transported active mulberry leaf phenolics inhibited adipogenesis through PPAR-γ and Leptin signaling pathway.
Li, E; Li, Q; Liao, S; Liu, F; Liu, T; Pang, D; Zou, Y, 2022
)
0.93
"Antiproliferative capabilities of rutin, benzoic acid (BA) and triazolofluoroqunolone (TFQ) derivatives were reported; hence chemosensitizing effects of rutin or its polymeric micelles (of improved solubility and bioavailability via direct dissolution using the amphiphilic copolymer Pluronic P123) in co-incubations with 5 BAs or 3 TFQ derivatives in a panel of 6 cancer cell lines were verified."( Preparation and Characterization of Rutin-Encapsulated Polymeric Micelles and Studies of Synergism with Bioactive Benzoic Acids and Triazolofluoroquinolones as Anticancer Nanomedicines.
Alhiari, Y; Alkhateeb, R; Ibrahim, R; Kasabri, V; Shalabi, D; Sunoqrot, S, 2023
)
1.39
" With slope-ratio assay using ADG and urinary hippuric acid as dependent variables and benzoic acid intake as an independent variable, the relative bioavailability of benzoic acid compared to sodium benzoate was not different."( Comparative effects of benzoic acid and sodium benzoate in diets for nursery pigs on growth performance and acidification of digesta and urine.
Chen, Y; Choi, H; Kim, SW; Longo, F, 2023
)
1.44
"The addition of protonating acids to e-cigarette liquid formulations (e-liquids) enhances nicotine bioavailability in e-cigarette use."( Assessing the impact of protonating acid combinations in e-cigarette liquids: a randomised, crossover study on nicotine pharmacokinetics.
Baxter-Wright, S; Ebajemito, J; Frosina, J; Hardie, G; McEwan, M; Taluskie, K; Thissen, J, 2023
)
0.91

Dosage Studied

The utility of high-resolution magic-angle spinning (HR-MAS) NMR for studying drug delivery in whole tissues was explored by dosing female Sprague-Dawley rats with topical or injectable benzoic acid (BA)

ExcerptRelevanceReference
" Comparison of dose-response curves for shift and block imposed by the inhibitor, indicate two different sites within the channel which interact with the ligand."( Identification and modulation of a voltage-dependent anion channel in the plasma membrane of guard cells by high-affinity ligands.
al-Awqati, Q; Hedrich, R; Landry, DW; Marten, I; Redhead, C; Zeilinger, C, 1992
)
0.28
" Therapy with benzoate, 500 mg/kg per day, was started on day 5, and the dosage was increased to 750 mg/kg per day on day 8, with prompt normalization of the neurologic and electroencephalographic findings."( Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
Francomano, CA; Hamosh, A; Johnston, MV; McDonald, JW; Niedermeyer, E; Valle, D, 1992
)
0.28
" The dose-response curve for butyric acid was shifted to the right in parallel in the solution containing succinic acid at 8 x 10(-4) mol/l."( Effects of butyric acid and analogues on amylase release from pancreatic segments of sheep and goats.
Katoh, K; Yajima, T, 1989
)
0.28
" The result showed that control animals dosed with 150 mg/kg benzoic acid resulted in urinary excretion of two metabolites, hippuric acid and benzoic acid glucuronide."( Benzoic acid metabolism in presence of Schistosoma mansoni infection in mice.
Emundianughe, TS, 1989
)
1.96
" In this study, dosing solutions of seven 14C-radiolabeled compounds representing three chemical classes--organic acid/base [benzoic acid (B), caffeine (C)], organophosphate (OP) pesticides (diisopropylfluorophosphidate, malathion, parathion), and steroid hormones (progesterone, testosterone)--were prepared in ethanol and applied topically at a surface concentration of 40 micrograms cm-2 to the IPPSF."( The isolated perfused porcine skin flap. III. Percutaneous absorption pharmacokinetics of organophosphates, steroids, benzoic acid, and caffeine.
Carver, MP; Riviere, JE; Williams, PL, 1989
)
0.69
"OH) radical was observed to affect cyclooxygenase metabolism in a dose-response manner."( Gender-related variations and interaction of human neutrophil cyclooxygenase and oxidative burst metabolites.
Bellanti, JA; Mallery, SR; Ramwell, PW; Zeligs, BJ, 1986
)
0.27
" In the child, when the benzoate/phenylacetate dosage was increased from 200 to 375 mg/kg/day each, feeding decreased."( Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
Batshaw, ML; Coyle, JT; Hyman, SL; Mellits, ED; Quaskey, S; Qureshi, IA; Robinson, MB, 1988
)
0.27
"An impurity present in all commercial guaifenesin-containing dosage forms examined was isolated and identified as 2-(2-methoxyphenoxy) 1,3-propanediol (VI)."( Determination of the structure of a synthetic impurity in guaifenesin: modification of a high-performance liquid chromatographic method for phenylephrine hydrochloride, phenylpropanolamine hydrochloride, guaifenesin, and sodium benzoate in dosage forms.
Lubey, GS; Newby, DG; Schieffer, GW; Smith, WO, 1984
)
0.27
" Dosage reduction in jaundiced infants and in those with demonstrated insufficiency of benzoate metabolism is recommended."( Disposition of sodium benzoate in newborn infants with hyperammonemia.
Freese, DK; Green, TP; Marchessault, RP, 1983
)
0.27
" In spite of the low dosage (10mg BA), the C3,5 resonances of [13C]HA were detected with favorable signal-to-noise ratios to quantitate [13C]HA concentration."( Use of nuclear magnetic resonance spectroscopy and selective C-labeling for pharmacokinetic research in man: detection of benzoic acid conversion to hippuric acid.
Akira, K; Baba, S; Imachi, M; Suzuki, H, 1995
)
0.5
"Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate were studied in male F344 rats and B6C3F1 mice."( Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate in rats and mice.
Abdo, K; Bugge, C; Clark, J; Espinosa, O; Garcia, D; Goehl, TJ; Yuan, JH, 1995
)
0.29
" In this study, we examined several aspects of ureagenesis after the single oral dosing of sodium benzoate in six healthy subjects who participated in the study previously reported and in two patients with citrullinaemia."( Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.
Ishizaki, T; Kubota, K, 1993
)
0.29
" Despite giving a higher dosage (240 mg/kg BM per day) normalization of glycine concentration in cerebrospinal fluid (CSF) was not achieved."( Response to sodium benzoate treatment in non-ketotic hyperglycinaemia.
Hobusch, D; Krüger, G; Radke, M; Stolpe, HJ; Tittelbach-Helmrich, W; Uhlemann, M; Walther, F, 1994
)
0.29
" Decreased responsiveness at high benzoate dosage indicates that the availability of coenzyme A is another factor that also limits the capacity of glycine conjugation."( Dependence of glycine conjugation on availability of glycine: role of the glycine cleavage system.
Fekete, T; Gregus, Z; Klaassen, CD; Varga, F, 1993
)
0.29
" In a mouse model of influenza, 5 did not protect the mice from weight loss due to the influenza virus when dosed intranasally."( Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Babu, YS; Bantia, S; Chand, P; Chu, N; Cole, LB; Kotian, PL; Laver, WG; Montgomery, JA; Pathak, VP; Petty, SL; Shrout, DP; Walsh, DA; Walsh, GM, 1997
)
0.6
"A pattern-fitting procedure for quantitative analysis of crystalline pharmaceuticals in solid dosage forms using X-ray powder diffraction data is described."( Quantitative analysis of crystalline pharmaceuticals in powders and tablets by a pattern-fitting procedure using X-ray powder diffraction data.
Momose, Y; Yamamura, S, 2001
)
0.31
" Further prospective studies should be performed to define the optimal dosage of sodium phenylbutyrate and the requirements for protein diet at different ages."( Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.
Burlina, AB; Korall, H; Ogier, H; Trefz, FK, 2001
)
0.31
" It may be concluded that, in developing models to describe the dissolution from solid dosage forms, it is not accurate to assume constant hydrodynamics and mass transfer rates at all surfaces of the system, or in different locations within the test device."( Sensitivity of dissolution rate to location in the paddle dissolution apparatus.
Corrigan, OI; Gallagher, KM; Healy, AM; McCarthy, LG, 2002
)
0.31
"The utility of high-resolution magic-angle spinning (HR-MAS) NMR for studying drug delivery in whole tissues was explored by dosing female Sprague-Dawley rats with topical or injectable benzoic acid (BA)."( Concentration profiling in rat tissue by high-resolution magic-angle spinning NMR spectroscopy: investigation of a model drug.
Larive, CK; Lucas, LH; Lunte, CE; Wilson, SF, 2005
)
0.52
"The purpose of this research was to develop a quantitative mass transport model to describe the release of a drug from a porous inert matrix dosage form near and below the percolation threshold for the system."( Percolative transport and cluster diffusion near and below the percolation threshold of a porous polymeric matrix.
Hastedt, JE; Wright, JL, 2006
)
0.33
" This new method can be utilized for routine analysis of FOS, CLO and ALN in dosage forms because of its efficiency, reliability, speed and simplicity."( Rapid analysis of alkylphosphonate drugs by capillary zone electrophoresis using indirect ultraviolet detection.
Prutthiwanasan, B; Suntornsuk, L, 2010
)
0.36
"Drug discovery is a complex process with the aim of discovering efficacious molecules where their potency and selectivity are balanced against ADMET properties to set the appropriate dose and dosing interval."( In silico physicochemical parameter predictions.
Barton, P; Wenlock, MC, 2013
)
0.39
" Moreover, the high dosage used indicates low potency of leonurine."( 3,5-Dimethoxy-4-(3-(2-carbonyl-ethyldisulfanyl)-propionyl)-benzoic acid 4-guanidino-butyl ester: a novel twin drug that prevents primary cardiac myocytes from hypoxia-induced apoptosis.
Gu, X; Guo, W; Liu, C; Maerz, S; Zhu, Y, 2013
)
0.63
" Statistically significant increases in the systemic exposure of ortho- and para-hydroxyatorvastatin were also observed upon concomitant dosing with CP-778875."( Elucidation of the biochemical basis for a clinical drug-drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778875), a subtype selective agonist of the peroxisome proliferator-activated recep
Chen, D; Feng, B; Francone, OL; Frederick, KS; Goosen, TC; Gosset, JR; Kalgutkar, AS; Rotter, CJ; Scialis, RJ; Terra, SG; Varma, MV; Walsky, RL; West, MA, 2013
)
0.59
" Physicians should therefore be aware of the potential for lung dosing with irritants when patients self-medicate using the Nelson Inhaler with vaporizing formulations such as Friars' Balsam."( Dispersing the Mists: An Experimental History of Medicine Study into the Quality of Volatile Inhalations.
Gallagher, CT; Moshksar, R; Murnane, B; Murnane, D; Sanders, M; Snell, N, 2017
)
0.46
" Moreover ,the proposed methods were successfully applied for determination of the studied drug in its pharmaceutical dosage form."( Different Chromatographic Methods for Simultaneous Determination of Mefenamic Acid and Two of Its Toxic Impurities.
Abdelwahab, NS; Ali, NW; Elsaady, MT; Morcoss, MM, 2017
)
0.46
"Frogs have permeable skin, so transdermal delivery provides a practical alternative to traditional dosing routes."( Percutaneous absorption between frog species: Variability in skin may influence delivery of therapeutics.
Berger, L; Glass, BD; Llewelyn, VK, 2020
)
0.56
"5 T scanner in order to evaluate the dose-response sensitivity and to study the effect of benzoic acid concentration, diffusion coefficient and temperature and to determine the temporal stability of the gel dosimeter."( Evaluation of ferrous benzoic methylthymol-blue gel as a dosimeter via magnetic resonance imaging.
Farzin, M; Geraily, G; Mehri-Kakavand, G; Parwaie, W; Shirazi, A, 2020
)
0.78
"GSK3532795 (formerly BMS-955176) is a second-generation HIV-1 maturation inhibitor that has shown broad spectrum antiviral activity and preclinical PK predictive of once-daily dosing in humans."( Design and exploration of C-3 benzoic acid bioisosteres and alkyl replacements in the context of GSK3532795 (BMS-955176) that exhibit broad spectrum HIV-1 maturation inhibition.
Beno, BR; Dicker, IB; Gupta, A; Hanumegowda, U; Jenkins, S; Krystal, M; Meanwell, NA; Ng, A; Parker, DD; Protack, T; Regueiro-Ren, A; Shanmugam, Y; Swidorski, JJ, 2021
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (89 Items)

ItemProcessFrequency
Beveragescore-ingredient106
Carbonated drinkscore-ingredient70
Sodascore-ingredient67
Energy drinkscore-ingredient55
Mexican Dinner Mixescore-ingredient45
Artificially sweetened beveragescore-ingredient14
Sweetened beveragescore-ingredient7
Open Beauty Factscore-ingredient7
Non food productscore-ingredient6
Energy drink without sugar and with artificial sweetenerscore-ingredient5
Plant-based foodscore-ingredient5
Plant-based foods and beveragescore-ingredient5
en:open-beauty-factscore-ingredient4
Boissonscore-ingredient4
Snackscore-ingredient3
Groceriescore-ingredient3
Saucescore-ingredient3
Condimentscore-ingredient3
Breadscore-ingredient3
Cereals and potatoescore-ingredient3
Energy drink with sugarcore-ingredient3
en:artificially-sweetened-beveragescore-ingredient3
Tortillascore-ingredient2
Boisson énergisante non sucrée avec édulcorantscore-ingredient2
Flatbreadscore-ingredient2
Boissons énergisantescore-ingredient2
Corn tortillascore-ingredient2
Tortillas de maïscore-ingredient2
Pains platscore-ingredient2
Painscore-ingredient2
Céréales et pommes de terrecore-ingredient2
Aliments d'origine végétalecore-ingredient2
Aliments et boissons à base de végétauxcore-ingredient2
énergisantescore-ingredient2
Corn chipscore-ingredient2
Crispscore-ingredient2
Chips and friescore-ingredient2
Appetizerscore-ingredient2
Salty snackscore-ingredient2
Frozen foodscore-ingredient2
édulcoréescore-ingredient1
Wheat flatbreadscore-ingredient1
Wheat breadscore-ingredient1
White breadscore-ingredient1
Corncore-ingredient1
Cereal grainscore-ingredient1
Sugarscore-ingredient1
Sweetenerscore-ingredient1
en:tortillascore-ingredient1
Cereals and their productscore-ingredient1
Seedscore-ingredient1
Meatscore-ingredient1
Meats and their productscore-ingredient1
Blueberry syrupscore-ingredient1
Flavoured syrupscore-ingredient1
Apple piescore-ingredient1
Piescore-ingredient1
Sweet piescore-ingredient1
Cakescore-ingredient1
Biscuits and cakescore-ingredient1
Sweet snackscore-ingredient1
Syrupscore-ingredient1
en:energy-drinkscore-ingredient1
en:Boissons énergisantescore-ingredient1
en:Boissons édulcoréescore-ingredient1
en:Boissons sans sucre ajoutécore-ingredient1
en:Boissons avec sucre ajoutécore-ingredient1
Non-alcoholic beveragescore-ingredient1
en:Boissonscore-ingredient1
en:Corn flatbreadscore-ingredient1
Panes planoscore-ingredient1
Panescore-ingredient1
Cereales y patatascore-ingredient1
Alimentos de origen vegetalcore-ingredient1
Alimentos y bebidas de origen vegetalcore-ingredient1
en:Non food productscore-ingredient1
Facial washcore-ingredient1
en:Boissons gazeusescore-ingredient1
Boissons édulcoréescore-ingredient1
Boissons et préparations de boissonscore-ingredient1
fr:Gel douchecore-ingredient1
Productos no alimenticioscore-ingredient1
Shower gelcore-ingredient1
Jamscore-ingredient1
Fruit and vegetable preservescore-ingredient1
Sweet spreadscore-ingredient1
Plant-based spreadscore-ingredient1
Spreadscore-ingredient1
Breakfastscore-ingredient1

Roles (7)

RoleDescription
antimicrobial food preservativeA food preservative which prevents decomposition of food by preventing the growth of fungi or bacteria. In European countries, E-numbers for permitted food preservatives are from E200 to E299, divided into sorbates (E200-209), benzoates (E210-219), sulfites (E220-229), phenols and formates (E230-239), nitrates (E240-259), acetates (E260-269), lactates (E270-279), propionates (E280-289) and others (E290-299).
EC 3.1.1.3 (triacylglycerol lipase) inhibitorAny EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that inhibits the action of triacylglycerol lipase (EC 3.1.1.3).
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitorA lipoxygenase inhibitor that interferes with the action of arachidonate 15-lipoxygenase (EC 1.13.11.33).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
drug allergenAny drug which causes the onset of an allergic reaction.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (25)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase II - Conjugation of compounds73122
Amino Acid conjugation015
Conjugation of carboxylic acids015
Conjugation of benzoate with glycine08
benzoate degradation II (aerobic and anaerobic)36
2-hydroxybiphenyl degradation011
amygdalin and prunasin degradation09
ephedrine biosynthesis019
superpathway of tetrahydroxyxanthone biosynthesis026
salicin biosynthesis012
salicortin biosynthesis017
volatile benzenoid biosynthesis I (ester formation)119
benzoate biosynthesis I (CoA-dependent, u03B2-oxidative)119
benzoyl-u03B2-D-glucopyranose biosynthesis34
tetrahydroxyxanthone biosynthesis (from benzoate)022
benzoate biosynthesis II (CoA-independent, non-u03B2-oxidative)011
benzoate biosynthesis III (CoA-dependent, non-u03B2-oxidative)016
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
Flavan-3-ol metabolic pathway070
Toluene degradation05
AtMetExpress overview0109
Amino acid conjugation of benzoic acid09
Salicylate biosynthesis116

Protein Targets (27)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency93.89680.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency3.73810.002541.796015,848.9004AID1347395
GLI family zinc finger 3Homo sapiens (human)Potency0.64190.000714.592883.7951AID1259369
thyroid stimulating hormone receptorHomo sapiens (human)Potency10.00000.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency37.44440.000657.913322,387.1992AID1259377; AID1259394
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency39.99190.001022.650876.6163AID1224838; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency37.05740.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency40.15830.000229.305416,493.5996AID743075; AID743077; AID743079
lethal factor (plasmid)Bacillus anthracis str. A2012Potency1.25890.020010.786931.6228AID912
Cellular tumor antigen p53Homo sapiens (human)Potency0.25550.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Oxygen-insensitive Nad(p)h NitroreductaseEnterobacter cloacaeKi100.0000100.0000100.0000100.0000AID977610
Chain B, Oxygen-insensitive Nad(p)h NitroreductaseEnterobacter cloacaeKi100.0000100.0000100.0000100.0000AID977610
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)425.32200.03403.987110.0000AID1059453; AID1082239; AID1628074; AID1628075; AID1628079
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Ki54.00000.00000.12345.5000AID726215
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Ki54.00000.00000.10825.5000AID726215
TyrosinaseHomo sapiens (human)Ki520.00001.70004.73339.1000AID1717714
D-amino-acid oxidaseHomo sapiens (human)IC50 (µMol)62.17230.00401.119910.0000AID1247844; AID726221; AID726222; AID745648
D-amino-acid oxidaseHomo sapiens (human)Ki22.28000.01302.13868.1600AID726204; AID726213; AID726214; AID726215; AID745647
Nicotinate phosphoribosyltransferaseHomo sapiens (human)Ki0.00190.00000.00060.0019AID1618606
Solute carrier family 22 member 20Mus musculus (house mouse)Ki13.80191.10006.67899.1201AID360149
Solute carrier family 22 member 6Mus musculus (house mouse)Ki252.09450.40745.02179.4000AID360150
D-aspartate oxidaseHomo sapiens (human)IC50 (µMol)10,000.00000.00400.39370.8550AID1247843; AID726223
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
D-amino-acid oxidaseSus scrofa (pig)Kd2.30000.15002.81006.3000AID745649
D-amino-acid oxidaseHomo sapiens (human)Kd4.50000.00311.72789.0000AID745628; AID745649; AID745651
Metabotropic glutamate receptor 5Homo sapiens (human)EC50 (µMol)10.00000.00190.61454.1000AID770257
Beta-lactamase Klebsiella pneumoniaeKd1,000.00000.85000.85000.8500AID1320842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Monocarboxylate transporter 1Rattus norvegicus (Norway rat)Km3.05002.28002.66503.0500AID679949
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (177)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
proline catabolic processD-amino-acid oxidaseHomo sapiens (human)
digestionD-amino-acid oxidaseHomo sapiens (human)
D-amino acid catabolic processD-amino-acid oxidaseHomo sapiens (human)
D-serine catabolic processD-amino-acid oxidaseHomo sapiens (human)
dopamine biosynthetic processD-amino-acid oxidaseHomo sapiens (human)
D-alanine catabolic processD-amino-acid oxidaseHomo sapiens (human)
D-serine metabolic processD-amino-acid oxidaseHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumD-amino-acid oxidaseHomo sapiens (human)
desensitization of G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of DNA-templated transcriptionMetabotropic glutamate receptor 5Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
phospholipase C-activating G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 5Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 5Homo sapiens (human)
learning or memoryMetabotropic glutamate receptor 5Homo sapiens (human)
learningMetabotropic glutamate receptor 5Homo sapiens (human)
locomotory behaviorMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of MAPK cascadeMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of long-term neuronal synaptic plasticityMetabotropic glutamate receptor 5Homo sapiens (human)
synapse organizationMetabotropic glutamate receptor 5Homo sapiens (human)
positive regulation of calcium-mediated signalingMetabotropic glutamate receptor 5Homo sapiens (human)
cognitionMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 5Homo sapiens (human)
cellular response to amyloid-betaMetabotropic glutamate receptor 5Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 5Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionMetabotropic glutamate receptor 5Homo sapiens (human)
response to oxidative stressNicotinate phosphoribosyltransferaseHomo sapiens (human)
NAD salvageNicotinate phosphoribosyltransferaseHomo sapiens (human)
inseminationD-aspartate oxidaseHomo sapiens (human)
grooming behaviorD-aspartate oxidaseHomo sapiens (human)
regulation of cell communicationD-aspartate oxidaseHomo sapiens (human)
D-amino acid catabolic processD-aspartate oxidaseHomo sapiens (human)
hormone metabolic processD-aspartate oxidaseHomo sapiens (human)
nervous system processD-aspartate oxidaseHomo sapiens (human)
aspartate catabolic processD-aspartate oxidaseHomo sapiens (human)
L-serine metabolic processSerine racemaseHomo sapiens (human)
serine family amino acid metabolic processSerine racemaseHomo sapiens (human)
response to xenobiotic stimulusSerine racemaseHomo sapiens (human)
response to organic cyclic compoundSerine racemaseHomo sapiens (human)
response to lipopolysaccharideSerine racemaseHomo sapiens (human)
pyruvate biosynthetic processSerine racemaseHomo sapiens (human)
D-serine metabolic processSerine racemaseHomo sapiens (human)
D-serine biosynthetic processSerine racemaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (61)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
D-amino-acid oxidase activityD-amino-acid oxidaseHomo sapiens (human)
protein bindingD-amino-acid oxidaseHomo sapiens (human)
identical protein bindingD-amino-acid oxidaseHomo sapiens (human)
FAD bindingD-amino-acid oxidaseHomo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 5Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
protein tyrosine kinase activator activityMetabotropic glutamate receptor 5Homo sapiens (human)
A2A adenosine receptor bindingMetabotropic glutamate receptor 5Homo sapiens (human)
identical protein bindingMetabotropic glutamate receptor 5Homo sapiens (human)
protein tyrosine kinase bindingMetabotropic glutamate receptor 5Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 5Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 5Homo sapiens (human)
G protein-coupled receptor activity involved in regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 5Homo sapiens (human)
nicotinate phosphoribosyltransferase activityNicotinate phosphoribosyltransferaseHomo sapiens (human)
protein bindingNicotinate phosphoribosyltransferaseHomo sapiens (human)
transferase activityNicotinate phosphoribosyltransferaseHomo sapiens (human)
metal ion bindingNicotinate phosphoribosyltransferaseHomo sapiens (human)
protein bindingD-aspartate oxidaseHomo sapiens (human)
D-aspartate oxidase activityD-aspartate oxidaseHomo sapiens (human)
D-glutamate oxidase activityD-aspartate oxidaseHomo sapiens (human)
FAD bindingD-aspartate oxidaseHomo sapiens (human)
magnesium ion bindingSerine racemaseHomo sapiens (human)
L-serine ammonia-lyase activitySerine racemaseHomo sapiens (human)
calcium ion bindingSerine racemaseHomo sapiens (human)
protein bindingSerine racemaseHomo sapiens (human)
ATP bindingSerine racemaseHomo sapiens (human)
D-serine ammonia-lyase activitySerine racemaseHomo sapiens (human)
glycine bindingSerine racemaseHomo sapiens (human)
threonine racemase activitySerine racemaseHomo sapiens (human)
PDZ domain bindingSerine racemaseHomo sapiens (human)
pyridoxal phosphate bindingSerine racemaseHomo sapiens (human)
serine racemase activitySerine racemaseHomo sapiens (human)
identical protein bindingSerine racemaseHomo sapiens (human)
protein homodimerization activitySerine racemaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (43)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
mitochondrial outer membraneD-amino-acid oxidaseHomo sapiens (human)
extracellular regionD-amino-acid oxidaseHomo sapiens (human)
cytoplasmD-amino-acid oxidaseHomo sapiens (human)
peroxisomal matrixD-amino-acid oxidaseHomo sapiens (human)
cytosolD-amino-acid oxidaseHomo sapiens (human)
cell projectionD-amino-acid oxidaseHomo sapiens (human)
presynaptic active zoneD-amino-acid oxidaseHomo sapiens (human)
cytoplasmD-amino-acid oxidaseHomo sapiens (human)
dendriteMetabotropic glutamate receptor 5Homo sapiens (human)
cytoplasmMetabotropic glutamate receptor 5Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 5Homo sapiens (human)
dendritic spineMetabotropic glutamate receptor 5Homo sapiens (human)
dendritic shaftMetabotropic glutamate receptor 5Homo sapiens (human)
astrocyte projectionMetabotropic glutamate receptor 5Homo sapiens (human)
Schaffer collateral - CA1 synapseMetabotropic glutamate receptor 5Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 5Homo sapiens (human)
postsynaptic density membraneMetabotropic glutamate receptor 5Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 5Homo sapiens (human)
extracellular regionNicotinate phosphoribosyltransferaseHomo sapiens (human)
cytosolNicotinate phosphoribosyltransferaseHomo sapiens (human)
azurophil granule lumenNicotinate phosphoribosyltransferaseHomo sapiens (human)
extracellular exosomeNicotinate phosphoribosyltransferaseHomo sapiens (human)
cytosolNicotinate phosphoribosyltransferaseHomo sapiens (human)
peroxisomeD-aspartate oxidaseHomo sapiens (human)
peroxisomeD-aspartate oxidaseHomo sapiens (human)
peroxisomal matrixD-aspartate oxidaseHomo sapiens (human)
cytosolD-aspartate oxidaseHomo sapiens (human)
cytoplasmD-aspartate oxidaseHomo sapiens (human)
cytoplasmSerine racemaseHomo sapiens (human)
cytosolSerine racemaseHomo sapiens (human)
neuronal cell bodySerine racemaseHomo sapiens (human)
apical part of cellSerine racemaseHomo sapiens (human)
cytoplasmSerine racemaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (209)

Assay IDTitleYearJournalArticle
AID1081625Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID770257Positive allosteric modulation of human mGluR5a transfected in HEK293 cells by calcium mobilization assay2013Journal of medicinal chemistry, Sep-26, Volume: 56, Issue:18
Dihydrothiazolopyridone derivatives as a novel family of positive allosteric modulators of the metabotropic glutamate 5 (mGlu5) receptor.
AID1082344Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID404684Antifungal activity against Cochliobolus lunatus at 0.1 mM assessed as radial growth rate2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.
AID1082326Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082335Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID147482In vitro inhibitory activity against H1N9 strain of Influenza neuraminidase (membrane) at 7 mM concentration1997Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
AID1101859Antifungal activity against Saccharomyces cerevisiae ATCC 7754 at pH 5 after 48 hr by microdilution method2002Journal of agricultural and food chemistry, Jul-03, Volume: 50, Issue:14
Molecular design of antifungal agents.
AID1082359Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082358Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1372697Inhibition of mushroom tyrosinase using tyrosine as substrate pretreated for 5 mins followed by substrate addition measured after 20 mins by ELISA2018Bioorganic & medicinal chemistry, 01-15, Volume: 26, Issue:2
Characterization of tyrosinase inhibitory constituents from the aerial parts of Humulus japonicus using LC-MS/MS coupled online assay.
AID28926Effective permeability corrected for ionization2001Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
AID781325pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 20092014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID1082347Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID28921Partition coefficient (logP) (hexadecane)2001Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
AID23254Partition coefficient (logP) (chloroform)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1145608Drug absorption in anesthetized rat colon at pH 6.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID293934Inhibition of pieris rapae Phenoloxidase2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
AID1082236Inhibition of Bos taurus (bovine) CAT in liver2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID726215Inhibition of human recombinant N-terminal His-tagged DAO Y224F mutant expressed in Escherichia coli BL21(DE3) using D-alanine as substrate after 10 mins by Lineweaver-Burk plot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID197596Lysozyme-conjugated prodrugs: in vitro stability at pH 51992Journal of medicinal chemistry, Apr-03, Volume: 35, Issue:7
Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
AID1081642Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress root growth at 25 degC after 72 hr by laboratory-based agar medium bioassay2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1145605Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID114585Hydroxyl radical scavenging activity by chemiluminescence technique in mouse thymus cells2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Different hydroxyl radical scavenging activity of water-soluble beta-alanine C60 adducts.
AID745649Binding affinity to human recombinant DAAO by stopped flow spectrophotometric analysis in presence of FAD2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
AID1628079Inhibition of mushroom tyrosinase using L-DOPA as substrate preincubated for 5 mins followed by substrate addition measured for 2 mins by spectrophotometric analysis2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1081612Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1762125Estrogenic activity at human ER-positive MCF7 cells assessed as increase in cell proliferation at 50 uM incubated for 144 hrs by Soto's E-screen assay2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40Estrogenic activity of ethyl gallate and its potential use in hormone replacement therapy.
AID1145610Dissociation constant, pKa of the compound at pH 6.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1586851Displacement of DC271 from CRABP2 (unknown origin) at 200 to 1600 nM by fluorescence assay2018ACS medicinal chemistry letters, Dec-13, Volume: 9, Issue:12
Novel Fluorescence Competition Assay for Retinoic Acid Binding Proteins.
AID1082340Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID477928Cytotoxicity against human PANC1 cells in nutrient-deprived condition assessed as preferential cell death after 24 hrs by trypan blue dye exclusion method2010Journal of natural products, Apr-23, Volume: 73, Issue:4
Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells.
AID28693Concentration of the drug in the liver of rat1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1145616Increase in membrane potential in mollusc neurons assessed as conductance of potassium at pH 7.8 relative to salicylic acid1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1059453Inhibition of mushroom tyrosinase using L-tyrosine as substrate preincubated for 10 mins followed by enzyme addition measured after 20 mins by microplate reader analysis2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition.
AID23255Partition coefficient (logP) (ether)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID404686Antifungal activity against Cochliobolus lunatus2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.
AID781330pKa (acid-base dissociation constant) as determined by potentiometric titration2014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID28666log (1/C') was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1081617Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1082355Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082332Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1134602Hexane-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID197602Lysozyme-conjugated prodrugs: in vitro stability in rat cortical homogenate at pH 7.41992Journal of medicinal chemistry, Apr-03, Volume: 35, Issue:7
Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
AID1082339Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1081616Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID631927Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously measured after 24 hrs2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID1247844Inhibition of human recombinant DAO expressed in Escherichia coli BL21(DE3) using D-Asp and D-Ala assessed as 2-oxo acid production after 10 mins by colorimetric assay2015Journal of medicinal chemistry, Sep-24, Volume: 58, Issue:18
Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro.
AID745628Binding affinity to human recombinant DAAO at 492 nm spectral modification by spectrophotometric analysis in presence of FAD2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
AID745647Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serine2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
AID1762120Cytotoxicity against human ER-positive MCF7 cells assessed as increase in cell proliferation at 12.5 to 100 uM incubated for 24 hrs2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40Estrogenic activity of ethyl gallate and its potential use in hormone replacement therapy.
AID28692Concentration of the drug in the kidney of rat1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1145615Dissociation constant, pKa of the compound at pH 7.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1082357Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID404683Antifungal activity against Cochliobolus lunatus at 0.1 mM assessed as initial growth inhibition time2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.
AID404685Antifungal activity against Cochliobolus lunatus delta bph at 5 mM assessed as radial growth rate2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.
AID1083149Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions2012Journal of agricultural and food chemistry, Nov-28, Volume: 60, Issue:47
Nematotoxic phenolic compounds from Melia azedarach against Meloidogyne incognita.
AID1081623Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID384955Intrinsic aqueous solubility at pH 10 by shake-flask method2008Journal of medicinal chemistry, May-22, Volume: 51, Issue:10
Molecular characteristics for solid-state limited solubility.
AID1717714Mixed inhibition of recombinant human tyrosinase expressed in baculovirus infected sf9 cells using L-DOPA as substrate by double-reciprocal plot analysis2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
AID1081607Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1101856Antifungal activity against Saccharomyces cerevisiae ATCC 7754 at pH 3 after 48 hr by microdilution method2002Journal of agricultural and food chemistry, Jul-03, Volume: 50, Issue:14
Molecular design of antifungal agents.
AID226477Hammett constant was determined1993Journal of medicinal chemistry, Oct-01, Volume: 36, Issue:20
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
AID1059449Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 100 uM preincubated for 10 mins followed by enzyme addition measured after 20 mins by microplate reader analysis relative to control2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition.
AID360150Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID781326pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X2014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID1082329Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1127992Inhibition of NorA in fluoroquinolone-resistant Staphylococcus aureus 1199B assessed as potentiation of 4 ug/ml of ciprofloxacin MIC at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID726216Competitive inhibition of human recombinant N-terminal His-tagged DAO expressed in Escherichia coli BL21(DE3) using D-alanine as substrate by Lineweaver-Burk plot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID197600Lysozyme-conjugated prodrugs: in vitro stability in rat cortical homogenate at pH 51992Journal of medicinal chemistry, Apr-03, Volume: 35, Issue:7
Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
AID1082338Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082343Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082346Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1081637Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress shoot growth at 25 degC after 72 hr by laboratory-based agar medium bioassay2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID404682Antifungal activity against Cochliobolus lunatus at 5 mM assessed as radial growth rate2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.
AID310931Partition coefficient, log P of the compound2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID1127995Toxicity in Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1082337Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID310932Permeability across human Skin2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID1082231Inhibition of Oryctolagus cuniculus (rabbit) AOX in liver cytosol at IC50 concentration2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID726213Inhibition of human recombinant N-terminal His-tagged DAO expressed in Escherichia coli BL21(DE3) using D-serine as substrate by Lineweaver-Burk plot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID1081639Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress root growth at 25 degC after 72 hr by laboratory-based agar medium bioassay2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1082348Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1101861Antifungal activity against Saccharomyces cerevisiae ATCC 7754 at pH 9 after 48 hr by microdilution method2002Journal of agricultural and food chemistry, Jul-03, Volume: 50, Issue:14
Molecular design of antifungal agents.
AID1082351Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID430001Stability at pH 7.4 at 80 uM during 1 day by HPLC in presence of linoleic acid and azo-bis-isobutyronitrile2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
In vitro and in vivo studies of 6,8-(diaryl)imidazo[1,2-a]pyrazin-3(7H)-ones as new antioxidants.
AID1101860Antifungal activity against Saccharomyces cerevisiae ATCC 7754 at pH 7 after 48 hr by microdilution method2002Journal of agricultural and food chemistry, Jul-03, Volume: 50, Issue:14
Molecular design of antifungal agents.
AID1145614Dissociation constant, pKa of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1628073Ratio of IC50 for mushroom tyrosinase diphenolase activity using L-DOPA as substrate to IC50 for mushroom tyrosinase monophenolase activity using L-tyrosine as substrate2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1082331Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1127996Toxicity in fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID385427Inhibition of soybean 15-lipoxygenase2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Inhibition of 15-lipoxygenase-catalysed oxygenation of arachidonic acid by substituted benzoic acids.
AID1081618Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID726221Inhibition of human recombinant N-terminal His-tagged DAO expressed in Escherichia coli BL21(DE3) using D-alanine as substrate by colorimetric assay2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID1082238Inhibition of Oryctolagus cuniculus (rabbit) AOX in liver cytosol2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1059454Antioxidant activity assessed as trolox equivalent of APPH-induced peroxyl radical scavenging activity at 5 to 20 uM measured every 1 min for 120 mins by ORAC fluorescence assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition.
AID1082333Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID226478Hammett constant was evaluated1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
AID1082239Inhibition of Agaricus bisporus (mushroom) tyrosinase2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1848086Antimycobacterial activity against Mycobacterium bovis BCG Pasteur ATCC35734 assessed as inhibition of bacterial growth incubated for 5 days by broth microdilution method2022Bioorganic & medicinal chemistry, 11-15, Volume: 74Structure activity relationship of pyrazinoic acid analogs as potential antimycobacterial agents.
AID745648Competitive inhibition of human recombinant DAAO after 1 hr by coupled enzyme assay in presence of D-serine2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
AID1433351Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID310933Permeability across PAMPA membrane after 7 hrs2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
AID1082352Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1433347Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID371730Dissociation constant, pKa of the compound2009Journal of medicinal chemistry, Jun-11, Volume: 52, Issue:11
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.
AID1082341Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID403754Antitubercular activity against Mycobacterium tuberculosis 90-2213872005Journal of natural products, Sep, Volume: 68, Issue:9
Antitubercular constituents from the stem wood of Cinnamomum kotoense.
AID1762126Cytotoxicity against human ER-positive MCF7 cells assessed as reduction in cell proliferation at 50 uM incubated for 144 hrs by Soto's E-screen assay2021Bioorganic & medicinal chemistry letters, 05-15, Volume: 40Estrogenic activity of ethyl gallate and its potential use in hormone replacement therapy.
AID1082328Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082237Inhibition of xanthine oxidase2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID682058TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.00476 uM, benzoic acid: 10000 uM) in OATP-B-expressing HEK293 cells2003The Journal of pharmacology and experimental therapeutics, Aug, Volume: 306, Issue:2
Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.
AID623337Cytotoxicity against human M14 cells at 1 to 50 uM after 48 hrs by MTT assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.
AID360149Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID1081610Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID302815Dissociation constant, pKa of the compound2007Bioorganic & medicinal chemistry letters, Dec-01, Volume: 17, Issue:23
8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors.
AID1149945Inhibition of chymotrypsin (unknown origin)1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
AID1433349Cytotoxicity against human A549 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID726204Inhibition of human recombinant DAO expressed in Escherichia coli BL21(DE3) by oxygraphic assay2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID1320843Inhibition of native signal containing Klebsiella pneumoniae OXA-48 using nitrocefin substrate pre-incubated for 5 mins before substrate addition2016Journal of medicinal chemistry, 06-09, Volume: 59, Issue:11
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
AID1060462Inhibition of Sir2p in yeast DMY2844 assessed as growth inhibition at 800 uM after 48 hrs2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Evaluation of benzoic acid derivatives as sirtuin inhibitors.
AID1082324Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID311366Lipophilicity, log P of the compound2007Bioorganic & medicinal chemistry, Nov-15, Volume: 15, Issue:22
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
AID726214Inhibition of human recombinant N-terminal His-tagged DAO Y224A mutant expressed in Escherichia coli BL21(DE3) using D-alanine as substrate after 10 mins by Lineweaver-Burk plot analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID1082349Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID360151Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID274670Inhibition of ADCS2006Journal of medicinal chemistry, Dec-14, Volume: 49, Issue:25
Aminodeoxychorismate synthase inhibitors from one-bead one-compound combinatorial libraries: "staged" inhibitor design.
AID1433345Induction of nerve growth factor secretion in rat C6 cells at 20 uM after 24 hrs by ELISA relative to control2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1145607Octanol-aqueous phase distribution coefficient, log D of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1628074Inhibition of mushroom tyrosinase monophenolase activity using L-tyrosine as substrate measured every 60 s for 25 times2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID74488Inhibitory activity against murine gelatinase B at 5 mM was determined2002Bioorganic & medicinal chemistry letters, Aug-19, Volume: 12, Issue:16
Design and synthesis of novel inhibitors of gelatinase B.
AID197598Lysozyme-conjugated prodrugs: in vitro stability at pH 7.41992Journal of medicinal chemistry, Apr-03, Volume: 35, Issue:7
Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
AID1081608Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1247843Inhibition of human recombinant DDO expressed in Escherichia coli BL21(DE3) using D-Asp and D-Ala assessed as 2-oxo acid production after 10 mins by colorimetric assay2015Journal of medicinal chemistry, Sep-24, Volume: 58, Issue:18
Identification of Novel D-Aspartate Oxidase Inhibitors by in Silico Screening and Their Functional and Structural Characterization in Vitro.
AID1628075Inhibition of mushroom tyrosinase diphenolase activity using L-DOPA as substrate measured every 30 s for 25 times2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors.
AID1082360Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082330Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1081609Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID23251Partition coefficient (logP)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1101855Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 48 hr by microdilution method2002Journal of agricultural and food chemistry, Jul-03, Volume: 50, Issue:14
Molecular design of antifungal agents.
AID452626Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by microscopic analysis2009Bioorganic & medicinal chemistry, Nov-15, Volume: 17, Issue:22
The lifespan-promoting effect of acetic acid and Reishi polysaccharide.
AID1082334Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID23256Partition coefficient (logP) (hexane)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID1717715Competitive inhibition of White button mushroom tyrosinase using L-DOPA as substrate by Lineweaver-Burk plot2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
AID1082232Inhibition of xanthine oxidase at IC50 concentration2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1145606Octanol-aqueous phase partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1081622Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
AID1082356Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082342Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID726218Binding affinity to human recombinant N-terminal His-tagged DAO expressed in Escherichia coli BL21(DE3) at 40 uM after 2 to 30 mins by absorption spectra analysis2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID1081641Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress shoot growth at 25 degC after 72 hr by laboratory-based agar medium bioassay2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1320842Binding affinity to native signal deficient and TEV cleavage site containing His-tagged Klebsiella pneumoniae OXA-48 expressed in Escherichia coli assessed as dissociation constant by SPR assay2016Journal of medicinal chemistry, 06-09, Volume: 59, Issue:11
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
AID726220Inhibition of human recombinant N-terminal His-tagged serine racemase expressed in Escherichia coli BL21(DE3) using L-serine as substrate after 10 mins by fluorescence assay2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID28691log LD50 was determined1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID726223Inhibition of human recombinant N-terminal His-tagged DDO expressed in Escherichia coli BL21(DE3) using D-aspartate as substrate by colorimetric assay2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID1081640Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress seed germination at 25 degC after 72 hr by laboratory-based agar medium bioassay2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID726222Inhibition of human recombinant N-terminal His-tagged DAO expressed in Escherichia coli BL21(DE3) using D-serine as substrate by colorimetric assay2013Journal of medicinal chemistry, Mar-14, Volume: 56, Issue:5
Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID23252Partition coefficient (logP) (benzene)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID781329pKa (acid-base dissociation constant) as determined by other workers2014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID404680Antifungal activity against Cochliobolus lunatus delta bph at 5 mM assessed as initial growth inhibition time2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.
AID1082323Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1134599CHCl3-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID681405TP_TRANSPORTER: inhibition of Indoxyl sulfate uptake (Indoxyl sulfate: 2 uM, Benzoic acid: 1000 uM) in Xenopus laevis oocytes2002Journal of neurochemistry, Oct, Volume: 83, Issue:1
Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
AID1433348Cytotoxicity against human BT549 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1082325Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1739641Antimycobacterial activity activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of microbial growth incubated for 4 weeks in culture medium at pH 6.82020European journal of medicinal chemistry, Aug-15, Volume: 200Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening.
AID745651Binding affinity to human recombinant DAAO at 442 nm spectral modification by spectrophotometric analysis in presence of FAD2013Journal of medicinal chemistry, May-09, Volume: 56, Issue:9
Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
AID1082327Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1081611Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID1082345Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID197730Lysozyme-conjugated prodrugs: in vitro stability in buffered plasma at pH 7.41992Journal of medicinal chemistry, Apr-03, Volume: 35, Issue:7
Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
AID679949TP_TRANSPORTER: uptake in MCT1-expressing MDA-MB231 cells1999The Journal of pharmacy and pharmacology, Oct, Volume: 51, Issue:10
Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1.
AID1433346Cytotoxicity against rat C6 cells assessed as cell viability at 20 uM by MTT assay relative to control2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1082350Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1433350Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID311367Permeability coefficient in human skin2007Bioorganic & medicinal chemistry, Nov-15, Volume: 15, Issue:22
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
AID1082336Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID28928Intrinsic permeability of the compound2001Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
AID631930Dissociation constant, pKa of the compound2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID1081638Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress seed germination at 25 degC after 72 hr by laboratory-based agar medium bioassay2010Journal of agricultural and food chemistry, Sep-22, Volume: 58, Issue:18
Herbicidal activity of cineole derivatives.
AID404681Antifungal activity against Cochliobolus lunatus at 5 mM assessed as initial growth inhibition time2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
CYP53A15 of Cochliobolus lunatus, a target for natural antifungal compounds.
AID23253Partition coefficient (logP) (carbon tetrachloride)1987Journal of medicinal chemistry, Jul, Volume: 30, Issue:7
The role of solvent-accessible surface area in determining partition coefficients.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1803326α-glucosidase Inhibitory Activity Assay from Article 10.3109/14756366.2012.719503: \\Structure-activity relationships of bergenin derivatives effect on a-glucosidase inhibition.\\2013Journal of enzyme inhibition and medicinal chemistry, Dec, Volume: 28, Issue:6
Structure-activity relationships of bergenin derivatives effect on α-glucosidase inhibition.
AID1811Experimentally measured binding affinity data derived from PDB2002The Journal of biological chemistry, Mar-29, Volume: 277, Issue:13
Structures of nitroreductase in three states: effects of inhibitor binding and reduction.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2002The Journal of biological chemistry, Mar-29, Volume: 277, Issue:13
Structures of nitroreductase in three states: effects of inhibitor binding and reduction.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,304)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990537 (23.31)18.7374
1990's437 (18.97)18.2507
2000's484 (21.01)29.6817
2010's626 (27.17)24.3611
2020's220 (9.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 117.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index117.37 (24.57)
Research Supply Index7.80 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index220.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (117.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials42 (1.75%)5.53%
Reviews57 (2.38%)6.00%
Case Studies65 (2.71%)4.05%
Observational0 (0.00%)0.25%
Other2,235 (93.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Benzoic Acid in Beverages: Establishing a Link Between Urinary Metabolites, Metabolic Dysregulation and Weight Loss Failure [NCT03190785]20 participants (Actual)Interventional2017-07-01Completed
A Phase 2 Open-Label, Single-Arm Trial of the Efficacy of Topical Remetinostat on Basal Cell Carcinoma in Patients [NCT03180528]Phase 230 participants (Actual)Interventional2018-07-07Completed
Randomized Study Comparing the Efficacy and Tolerance of a Lipophilic Hydroxy Acid Derivative of Salicylic Acid and 5% Benzoyl Peroxide in the Treatment of Facial Acne Vulgaris [NCT00624676]80 participants (Actual)Interventional2006-01-31Completed
A Phase 2 Open Label, Single Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel as Neoadjuvant Therapy in Patients Undergoing Surgical Resection of Squamous Cell Carcinoma (SCC) [NCT03875859]Phase 24 participants (Actual)Interventional2019-12-12Terminated(stopped due to The available study medication reached expiry (logistics).)
Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal in People With Chronic Pain Undergoing Voluntary Opioid Tapering: a Pilot Study [NCT04939623]Phase 240 participants (Anticipated)Interventional2023-10-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT03180528 (4) [back to overview]Number of Participants With a Decrease in Expression of the Hedgehog Biomarker Gene GLI1
NCT03180528 (4) [back to overview]Overall Response Rate
NCT03180528 (4) [back to overview]Adverse Events Contributing to Treatment Discontinuation or Interruption
NCT03180528 (4) [back to overview]Participants Who Discontinued Treatment or Had Treatment Interruption
NCT03875859 (3) [back to overview]Adverse Events Contributing to Treatment Discontinuation or Interruption
NCT03875859 (3) [back to overview]Participants Who Discontinued Treatment or Had Treatment Interruption
NCT03875859 (3) [back to overview]Overall Response (OR)

Number of Participants With a Decrease in Expression of the Hedgehog Biomarker Gene GLI1

The effect of topical remetinostat gel 1% on decreasing expression of Hedgehog biomarker gene GLI1 was determined using the RNeasy Fibrous Tissue Mini Kit (Qiagen, Valencia, CA), a polymerase chain reaction (PCR) test kit. The levels observed at baseline and after 6 weeks treatment were obtained. The outcome is reported as the number of subjects for whom a decrease in expression of the Hedgehog biomarker gene GLI1 was observed, a number without dispersion. (NCT03180528)
Timeframe: 6 weeks

InterventionParticipants (Count of Participants)
Treatment (Remetinostat)5

[back to top]

Overall Response Rate

"Overall response is defined as achieving either a complete response (CR) or a partial response (PR). Response is based on the Response Evaluation Criteria in Solid Tumors (RECIST), as follows.~CR = tumor lesion becomes undetectable~PR = ≥30% decrease in total tumor diameter~Overall response (OR) = CR+PR~Stable Disease (SD) = decrease in total tumor diameter is >0% and <30%~Progressive Disease (PD) = increase in total tumor diameter Exact binomial 90% confidence intervals (90%) will be computed for OR. The data are reported accord to the per protocol analysis, ie, including lesions for subjects who were <70% compliant with drug treatment. For subjects who were compliant but dropped out, data from their last study visit will be used if they contribute a biopsy. The analysis population will include the participants who have provided pre-treatment and post-treatment biopsies. The outcome is reported as the percent of tumor lesions that achieve OR, with 90% CI." (NCT03180528)
Timeframe: At 6 weeks

Interventionpercentage of tumor lesions (Number)
Treatment (Remetinostat)69.7

[back to top]

Adverse Events Contributing to Treatment Discontinuation or Interruption

Adverse events (AEs) contributing to treatment discontinuation or interruption are reported as the number of such events, a number without dispersion. (NCT03180528)
Timeframe: 6 weeks

Interventionadverse events (Number)
AEs contributing to treatment interruptionAEs contributing to treatment discontinuation
Treatment (Remetinostat)93

[back to top]

Participants Who Discontinued Treatment or Had Treatment Interruption

The number of participants who discontinued treatment or experienced treatment interruption within the first 6 weeks of treatment are reported as the number of such participants, a number without dispersion. (NCT03180528)
Timeframe: 6 weeks

InterventionParticipants (Count of Participants)
Participants who experienced treatment interruptionParticipants who discontinued treatment
Treatment (Remetinostat)53

[back to top]

Adverse Events Contributing to Treatment Discontinuation or Interruption

Adverse events (AEs) contributing to treatment discontinuation or interruption are reported as the number of such events, a number without dispersion. (NCT03875859)
Timeframe: 8 weeks

Interventionadverse events (Number)
Remetinostat1

[back to top]

Participants Who Discontinued Treatment or Had Treatment Interruption

The number of participants who discontinued treatment or experienced treatment interruption within the first 8 weeks of treatment are reported as the number of such participants, a number without dispersion. (NCT03875859)
Timeframe: 8 weeks

InterventionParticipants (Count of Participants)
Remetinostat1

[back to top]

Overall Response (OR)

"Overall response (OR) will be assessed in squamous cell carcinoma (SCC). Objective response (OR) will defined as the number of lesions with either a complete response (CR) or a partial response (PR) among all eligible and treated lesions, any time within 10 weeks.~Complete Response (CR) = Disappearance of target lesion~Partial Response (PR) = ≥ 30% decrease in the sum of the longest diameter of target lesion~Overall Response (OR) = CR + PR" (NCT03875859)
Timeframe: 10 weeks

Interventiontumor lesions (Number)
CRPROR
Remetinostat505

[back to top]